251 related articles for article (PubMed ID: 25466443)
1. Tigecycline for the Treatment of Severe and Severe Complicated Clostridium difficile Infection.
Britt NS; Steed ME; Potter EM; Clough LA
Infect Dis Ther; 2014 Dec; 3(2):321-31. PubMed ID: 25466443
[TBL] [Abstract][Full Text] [Related]
2. The outcome of patients with severe and severe-complicated Clostridium difficile infection treated with tigecycline combination therapy: a retrospective observational study.
Bishop EJ; Tiruvoipati R; Metcalfe J; Marshall C; Botha J; Kelley PG
Intern Med J; 2018 Jun; 48(6):651-660. PubMed ID: 29363242
[TBL] [Abstract][Full Text] [Related]
3. Use of intravenous tigecycline in patients with severe Clostridium difficile infection: a retrospective observational cohort study.
Gergely Szabo B; Kadar B; Szidonia Lenart K; Dezsenyi B; Kunovszki P; Fried K; Kamotsay K; Nikolova R; Prinz G
Clin Microbiol Infect; 2016 Dec; 22(12):990-995. PubMed ID: 27599690
[TBL] [Abstract][Full Text] [Related]
4. Tigecycline for the treatment of severe Clostridium difficile infection.
Larson KC; Belliveau PP; Spooner LM
Ann Pharmacother; 2011 Jul; 45(7-8):1005-10. PubMed ID: 21730279
[TBL] [Abstract][Full Text] [Related]
5. The role of tigecycline in the management of Clostridium difficile infection: a retrospective cohort study.
Manea E; Sojo-Dorado J; Jipa RE; Benea SN; Rodríguez-Baño J; Hristea A
Clin Microbiol Infect; 2018 Feb; 24(2):180-184. PubMed ID: 28642147
[TBL] [Abstract][Full Text] [Related]
6. Intravenous Tigecycline Facilitates Cure of Severe Clostridium difficile Infection (CDI) After Failure of Standard Therapy: A Case Report and Literature Review of Tigecycline Use in CDI.
Navalkele BD; Lerner SA
Open Forum Infect Dis; 2016 Apr; 3(2):ofw094. PubMed ID: 27419166
[TBL] [Abstract][Full Text] [Related]
7. Use of tigecycline for the management of Clostridium difficile colitis in oncology patients and case series of breakthrough infections.
Brinda BJ; Pasikhova Y; Quilitz RE; Thai CM; Greene JN
J Hosp Infect; 2017 Apr; 95(4):426-432. PubMed ID: 28153556
[TBL] [Abstract][Full Text] [Related]
8. Doxycycline and Tigecycline: Two Friendly Drugs with a Low Association with Clostridium Difficile Infection.
Hung YP; Lee JC; Lin HJ; Liu HC; Wu YH; Tsai PJ; Ko WC
Antibiotics (Basel); 2015 Jun; 4(2):216-29. PubMed ID: 27025622
[TBL] [Abstract][Full Text] [Related]
9. Tigecycline for the treatment of patients with Clostridium difficile infection: an update of the clinical evidence.
Kechagias KS; Chorepsima S; Triarides NA; Falagas ME
Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1053-1058. PubMed ID: 31927652
[TBL] [Abstract][Full Text] [Related]
10. Effects of tigecycline and vancomycin administration on established Clostridium difficile infection.
Theriot CM; Schumacher CA; Bassis CM; Seekatz AM; Young VB
Antimicrob Agents Chemother; 2015 Mar; 59(3):1596-604. PubMed ID: 25547352
[TBL] [Abstract][Full Text] [Related]
11. Comparison of treatment outcomes with vancomycin alone versus combination therapy in severe Clostridium difficile infection.
Bass SN; Bauer SR; Neuner EA; Lam SW
J Hosp Infect; 2013 Sep; 85(1):22-7. PubMed ID: 23876778
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility of Clostridium difficile isolates in Israel.
Tkhawkho L; Nitzan O; Pastukh N; Brodsky D; Jackson K; Peretz A
J Glob Antimicrob Resist; 2017 Sep; 10():161-164. PubMed ID: 28729205
[TBL] [Abstract][Full Text] [Related]
13. Treating Clostridium difficile infection in patients presenting with hematological malignancies: Are current guidelines applicable?
Robin C; Héquette-Ruz R; Guery B; Boyle E; Herbaux C; Galperine T
Med Mal Infect; 2017 Dec; 47(8):532-539. PubMed ID: 28823390
[TBL] [Abstract][Full Text] [Related]
14. Oral teicoplanin for successful treatment of severe refractory Clostridium difficile infection.
Popovic N; Korac M; Nesic Z; Milosevic B; Urosevic A; Jevtovic D; Pelemis M; Delic D; Prostran M; Milosevic I
J Infect Dev Ctries; 2015 Oct; 9(10):1062-7. PubMed ID: 26517480
[TBL] [Abstract][Full Text] [Related]
15. Is tigecycline a suitable option for Clostridium difficile infection? Evidence from the literature.
Di Bella S; Nisii C; Petrosillo N
Int J Antimicrob Agents; 2015 Jul; 46(1):8-12. PubMed ID: 25982915
[TBL] [Abstract][Full Text] [Related]
16. High in vitro activity of fidaxomicin against Clostridium difficile isolates from a university teaching hospital in China.
Cheng JW; Yang QW; Xiao M; Yu SY; Zhou ML; Kudinha T; Kong F; Liao JW; Xu YC
J Microbiol Immunol Infect; 2018 Jun; 51(3):411-416. PubMed ID: 28693926
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Clostridium difficile infection in a French university hospital.
Khanafer N; Blais L; Barbut F; Hirschel B; Vanhems P
Scand J Gastroenterol; 2015; 50(10):1253-60. PubMed ID: 25877477
[TBL] [Abstract][Full Text] [Related]
18. Characteristics and predictors of treatment failure with intravenous tigecycline monotherapy among adult patients with severe Clostridioides (Clostridium) difficile infection: a single-centre observational cohort study.
Szabo BG; Duma L; Lenart KS; Kiss R; Vad E; Petrik BR; Ostorhazi E; Kadar B
Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115231. PubMed ID: 33099134
[TBL] [Abstract][Full Text] [Related]
19. Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy.
Jardin CG; Palmer HR; Shah DN; Le F; Beyda ND; Jiang Z; Garey KW
J Hosp Infect; 2013 Sep; 85(1):28-32. PubMed ID: 23834988
[TBL] [Abstract][Full Text] [Related]
20. Clostridium difficile Diarrhea in the Elderly: Current Issues and Management Options.
Mizusawa M; Doron S; Gorbach S
Drugs Aging; 2015 Aug; 32(8):639-47. PubMed ID: 26233437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
